These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8257463)

  • 61. Adolescents' attitude towards carrier testing for cystic fibrosis and its relative stability over time.
    Welkenhuysen M; Evers-Kiebooms G; Decruyenaere M; Van den Berghe H; Bande-Knops J; Van Gerven V
    Eur J Hum Genet; 1996; 4(1):52-62. PubMed ID: 8800929
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mass screening for cystic fibrosis heterozygotes: two assay systems compared.
    Gilfillan A; Axton R; Brock DJ
    Clin Chem; 1994 Feb; 40(2):197-9. PubMed ID: 8313593
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Screening for cystic fibrosis carriers.
    Brock DJ
    Lancet; 1992 Oct; 340(8825):984. PubMed ID: 1357397
    [No Abstract]   [Full Text] [Related]  

  • 64. Population screening for cystic fibrosis.
    Brock D
    Am J Hum Genet; 1990 Jul; 47(1):164-5. PubMed ID: 2349944
    [No Abstract]   [Full Text] [Related]  

  • 65. Socioeconomic status and uptake of reproductive carrier screening in Australia.
    Robson SJ; Caramins M; Saad M; Suthers G
    Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):976-979. PubMed ID: 32748403
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An update on cystic fibrosis screening.
    Goetzinger KR; Cahill AG
    Clin Lab Med; 2010 Sep; 30(3):533-43. PubMed ID: 20638569
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Carrier detection and clinical uncertainty: the case for public health ethics.
    Miller FA; Hayeems RZ; Robert JS
    Am J Public Health; 2009 Aug; 99(8):1349-50. PubMed ID: 19542029
    [No Abstract]   [Full Text] [Related]  

  • 68. Heteroduplex formation in polymerase chain reaction.
    Anglani F; Picci L; Camporese C; Zacchello F
    Am J Hum Genet; 1990 Jul; 47(1):169-70. PubMed ID: 2349948
    [No Abstract]   [Full Text] [Related]  

  • 69. Why study the economics of screening for CF?
    Mugford M
    J Cyst Fibros; 2012 Jul; 11(4):265. PubMed ID: 22711021
    [No Abstract]   [Full Text] [Related]  

  • 70. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.
    Miedzybrodzka ZH; Hall MH; Mollison J; Templeton A; Russell IT; Dean JC; Kelly KF; Marteau TM; Haites NE
    BMJ; 1995 Feb; 310(6976):353-7. PubMed ID: 7866213
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detection of cystic-fibrosis genotypes.
    Katznelson D; Blau H; Sack J
    Lancet; 1983 Sep; 2(8350):622. PubMed ID: 6136766
    [No Abstract]   [Full Text] [Related]  

  • 72. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Highlighting the impact of cascade carrier testing in cystic fibrosis families.
    Duguépéroux I; L'Hostis C; Audrézet MP; Rault G; Frachon I; Bernard R; Parent P; Blayau M; Schmitt S; Génin E; Férec C; Scotet V
    J Cyst Fibros; 2016 Jul; 15(4):452-9. PubMed ID: 27013383
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expanded Carrier Screening.
    Gregg AR
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):103-112. PubMed ID: 29428278
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A universal array-based multiplexed test for cystic fibrosis carrier screening.
    Amos JA; Bridge-Cook P; Ponek V; Jarvis MR
    Expert Rev Mol Diagn; 2006 Jan; 6(1):15-22. PubMed ID: 16359263
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Screening for cystic fibrosis in primary care.
    Burn J
    BMJ; 1993 Jun; 306(6892):1558-9. PubMed ID: 8329910
    [No Abstract]   [Full Text] [Related]  

  • 77. Using the latest genome sequencing technologies to develop new carrier and prenatal genetic tests. Interview by Orla Smith.
    Jackson L
    Sci Transl Med; 2011 Jan; 3(65):65pc1. PubMed ID: 21284236
    [No Abstract]   [Full Text] [Related]  

  • 78. Proteus vulgaris agglutination by cystic fibrosis sera.
    Wang A; Turner MW; Soothill JF; Warner JO; Norman AP
    Arch Dis Child; 1980 Feb; 55(2):130-3. PubMed ID: 6990879
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lessons (re)learned from cystic fibrosis carrier screening.
    Clayton EW
    J Gend Specif Med; 1999; 2(6):21-4. PubMed ID: 11279867
    [No Abstract]   [Full Text] [Related]  

  • 80. Screening for carriers of cystic fibrosis--a general practitioner's perspective.
    Modell M
    BMJ; 1993 Oct; 307(6908):849-52. PubMed ID: 8401130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.